Indonesia

Indonesia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.43 (1.81 - 3.14) 2015 Modelled WHO
6.8 (6.30 - 8.20) 2016 Modelled Razavi-Shearer et al, 2018
1.86 (1.76 - 1.96) 2013 Modelled Schweitzer et al, 2015
3.62 (3.17 - 4.05) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.87 (3.40 - 4.32) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.87 (3.39 - 4.31) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.96 (3.48 - 4.42) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4.07 (3.57 - 4.52) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4.11 (3.62 - 4.58) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4.2 (3.69 - 4.67) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4.29 (3.78 - 4.78) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4.37 (3.85 - 4.88) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4.41 (3.88 - 4.93) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4.45 (3.92 - 4.98) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4.52 (3.98 - 5.06) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4.6 (4.05 - 5.14) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4.66 (4.10 - 5.22) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4.7 (4.12 - 5.26) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4.74 (4.15 - 5.31) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4.8 (4.22 - 5.39) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.87 (4.28 - 5.47) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.93 (4.34 - 5.54) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.96 (4.36 - 5.58) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.97 (4.37 - 5.59) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.99 (4.38 - 5.62) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5.01 (4.40 - 5.65) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5.03 (4.41 - 5.68) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5.03 (4.41 - 5.69) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5.02 (4.40 - 5.66) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5.01 (4.39 - 5.65) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5.01 (4.39 - 5.64) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5.01 (4.39 - 5.65) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5 (4.37 - 5.65) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.89 (3.43 - 4.36) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
1.07 (0.69 - 1.55) 2015 Modelled WHO
0.62 (0.49 - 0.76) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.76 (0.60 - 0.94) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.65 - 1) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.69 - 1.07) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.76 - 1.17) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.83 - 1.29) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.18 (0.94 - 1.46) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.37 (1.09 - 1.69) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.55 (1.24 - 1.92) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.36 - 2.10) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.76 (1.41 - 2.18) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.75 (1.40 - 2.16) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.69 (1.36 - 2.10) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.62 (1.30 - 2.01) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.56 (1.25 - 1.94) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.54 (1.23 - 1.91) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.54 (1.24 - 1.91) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.56 (1.26 - 1.94) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.59 (1.28 - 1.97) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.64 (1.32 - 2.02) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.36 - 2.09) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.87 (1.50 - 2.30) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.2 (1.76 - 2.70) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (2.06 - 3.16) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.89 (2.31 - 3.54) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.02 (2.41 - 3.70) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.03 (2.41 - 3.72) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.03 (2.42 - 3.73) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.03 (2.42 - 3.72) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.02 (2.42 - 3.69) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (2.40 - 3.67) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.3 (1.14 - 1.49) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
17,695,000 (16,451,000 - 21,531,000) 2016 Modelled Razavi-Shearer et al, 2018
9,384,600 (8,233,150 - 10,497,100) 2019 Modelled IHME, GBD 2019 (accessed 2020)
9,728,500 (8,550,680 - 10,871,900) 2019 Modelled IHME, GBD 2019 (accessed 2022)
9,616,480 (8,433,050 - 10,747,500) 2018 Modelled IHME, GBD 2019 (accessed 2022)
9,549,660 (8,377,220 - 10,680,500) 2017 Modelled IHME, GBD 2019 (accessed 2022)
9,701,340 (8,536,800 - 10,815,600) 2016 Modelled IHME, GBD 2019 (accessed 2022)
9,865,320 (8,661,700 - 10,965,000) 2015 Modelled IHME, GBD 2019 (accessed 2022)
9,897,770 (8,694,220 - 11,012,400) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10,006,500 (8,797,150 - 11,148,000) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10,133,200 (8,913,430 - 11,301,200) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10,221,500 (9,004,510 - 11,400,800) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10,217,000 (8,989,390 - 11,428,800) 2010 Modelled IHME, GBD 2019 (accessed 2022)
10,190,300 (8,982,030 - 11,405,200) 2009 Modelled IHME, GBD 2019 (accessed 2022)
10,218,700 (9,016,080 - 11,449,600) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10,261,500 (9,041,050 - 11,502,200) 2007 Modelled IHME, GBD 2019 (accessed 2022)
10,280,200 (9,027,820 - 11,522,900) 2006 Modelled IHME, GBD 2019 (accessed 2022)
10,237,600 (8,984,790 - 11,474,400) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10,208,100 (8,934,670 - 11,461,500) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10,246,000 (9,001,630 - 11,523,900) 2003 Modelled IHME, GBD 2019 (accessed 2022)
10,295,700 (9,072,320 - 11,588,200) 2002 Modelled IHME, GBD 2019 (accessed 2022)
10,311,500 (9,083,100 - 11,616,900) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10,244,900 (9,022,450 - 11,552,300) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10,140,900 (8,921,090 - 11,449,800) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10,061,600 (8,838,140 - 11,326,100) 1998 Modelled IHME, GBD 2019 (accessed 2022)
9,987,150 (8,756,920 - 11,243,400) 1997 Modelled IHME, GBD 2019 (accessed 2022)
9,898,010 (8,673,050 - 11,138,100) 1996 Modelled IHME, GBD 2019 (accessed 2022)
9,774,160 (8,566,050 - 11,032,400) 1995 Modelled IHME, GBD 2019 (accessed 2022)
9,629,000 (8,446,130 - 10,862,200) 1994 Modelled IHME, GBD 2019 (accessed 2022)
9,487,210 (8,313,850 - 10,679,900) 1993 Modelled IHME, GBD 2019 (accessed 2022)
9,346,810 (8,182,580 - 10,533,400) 1992 Modelled IHME, GBD 2019 (accessed 2022)
9,205,690 (8,053,490 - 10,411,500) 1991 Modelled IHME, GBD 2019 (accessed 2022)
9,061,620 (7,924,360 - 10,244,300) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
8.72 (7.10 - 10.60) 2019 Modelled IHME, GBD 2019 (accessed 2020)
9.87 (7.95 - 11.94) 1990 Modelled IHME, GBD 2019 (accessed 2022)
9.92 (8.02 - 11.93) 1991 Modelled IHME, GBD 2019 (accessed 2022)
9.99 (8.18 - 12.11) 1992 Modelled IHME, GBD 2019 (accessed 2022)
10.05 (8.19 - 12.10) 1993 Modelled IHME, GBD 2019 (accessed 2022)
10.09 (8.27 - 12.07) 1994 Modelled IHME, GBD 2019 (accessed 2022)
10.13 (8.46 - 12.09) 1995 Modelled IHME, GBD 2019 (accessed 2022)
10.15 (8.54 - 12.07) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10.22 (8.67 - 11.98) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10.18 (8.61 - 11.92) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10.31 (8.63 - 12.07) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10.27 (8.72 - 12.01) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10.37 (8.74 - 12.22) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10.53 (8.91 - 12.41) 2002 Modelled IHME, GBD 2019 (accessed 2022)
10.72 (9.09 - 12.70) 2003 Modelled IHME, GBD 2019 (accessed 2022)
10.91 (9.31 - 12.76) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10.85 (9.15 - 12.83) 2006 Modelled IHME, GBD 2019 (accessed 2022)
11.02 (9.23 - 12.93) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10.33 (8.65 - 12.14) 2007 Modelled IHME, GBD 2019 (accessed 2022)
9.65 (8.06 - 11.31) 2008 Modelled IHME, GBD 2019 (accessed 2022)
8.72 (7.40 - 10.42) 2010 Modelled IHME, GBD 2019 (accessed 2022)
9.06 (7.59 - 10.68) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8.64 (7.21 - 10.32) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8.54 (7.18 - 10.13) 2012 Modelled IHME, GBD 2019 (accessed 2022)
8.27 (6.72 - 10.02) 2015 Modelled IHME, GBD 2019 (accessed 2022)
8.42 (6.92 - 10.19) 2014 Modelled IHME, GBD 2019 (accessed 2022)
8.48 (7.07 - 10.18) 2013 Modelled IHME, GBD 2019 (accessed 2022)
8.33 (6.83 - 10.07) 2016 Modelled IHME, GBD 2019 (accessed 2022)
8.45 (6.81 - 10.47) 2017 Modelled IHME, GBD 2019 (accessed 2022)
8.56 (7.02 - 10.47) 2018 Modelled IHME, GBD 2019 (accessed 2022)
8.72 (7.10 - 10.61) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
30,566 2016 Modelled WHO
18,306 (14,741 - 22,140) 1990 Modelled IHME, GBD 2019 (accessed 2022)
18,687 (15,107 - 22,454) 1991 Modelled IHME, GBD 2019 (accessed 2022)
19,096 (15,641 - 23,148) 1992 Modelled IHME, GBD 2019 (accessed 2022)
19,859 (16,286 - 23,757) 1994 Modelled IHME, GBD 2019 (accessed 2022)
19,499 (15,893 - 23,478) 1993 Modelled IHME, GBD 2019 (accessed 2022)
20,215 (16,885 - 24,133) 1995 Modelled IHME, GBD 2019 (accessed 2022)
20,553 (17,293 - 24,445) 1996 Modelled IHME, GBD 2019 (accessed 2022)
20,888 (17,677 - 24,474) 1997 Modelled IHME, GBD 2019 (accessed 2022)
21,262 (18,044 - 24,914) 1998 Modelled IHME, GBD 2019 (accessed 2022)
21,649 (18,384 - 25,312) 1999 Modelled IHME, GBD 2019 (accessed 2022)
22,035 (18,432 - 25,777) 2000 Modelled IHME, GBD 2019 (accessed 2022)
22,442 (18,918 - 26,456) 2001 Modelled IHME, GBD 2019 (accessed 2022)
23,091 (19,527 - 27,200) 2002 Modelled IHME, GBD 2019 (accessed 2022)
23,812 (20,177 - 28,205) 2003 Modelled IHME, GBD 2019 (accessed 2022)
24,510 (20,924 - 28,665) 2004 Modelled IHME, GBD 2019 (accessed 2022)
24,062 (20,136 - 28,260) 2007 Modelled IHME, GBD 2019 (accessed 2022)
24,978 (21,055 - 29,536) 2006 Modelled IHME, GBD 2019 (accessed 2022)
25,055 (21,000 - 29,411) 2005 Modelled IHME, GBD 2019 (accessed 2022)
22,727 (18,985 - 26,637) 2008 Modelled IHME, GBD 2019 (accessed 2022)
21,588 (18,068 - 25,444) 2009 Modelled IHME, GBD 2019 (accessed 2022)
20,980 (17,806 - 25,074) 2010 Modelled IHME, GBD 2019 (accessed 2022)
21,004 (17,526 - 25,102) 2011 Modelled IHME, GBD 2019 (accessed 2022)
20,962 (17,631 - 24,870) 2012 Modelled IHME, GBD 2019 (accessed 2022)
21,007 (17,528 - 25,242) 2013 Modelled IHME, GBD 2019 (accessed 2022)
21,163 (17,345 - 25,590) 2016 Modelled IHME, GBD 2019 (accessed 2022)
20,858 (16,936 - 25,252) 2015 Modelled IHME, GBD 2019 (accessed 2022)
21,053 (17,314 - 25,490) 2014 Modelled IHME, GBD 2019 (accessed 2022)
21,630 (17,426 - 26,815) 2017 Modelled IHME, GBD 2019 (accessed 2022)
22,062 (18,107 - 26,997) 2018 Modelled IHME, GBD 2019 (accessed 2022)
22,614 (18,419 - 27,519) 2019 Modelled IHME, GBD 2019 (accessed 2022)
22,614 (18,419 - 27,519) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
4 (3 - 5) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 5) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5 (5 - 6) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5 (5 - 6) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5 (5 - 6) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5 (5 - 6) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5 (5 - 7) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2018 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2019 Modelled IHME, GBD 2019 (accessed 2022)
21 (18 - 24) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
84 2019 Survey/reported WHO/UNICEF
54 2018 Survey/reported WHO/UNICEF
32 2017 Survey/reported WHO/UNICEF
73 2020 Survey/reported WHO/UNICEF
70 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
85 2019 Survey/reported WHO/UNICEF
77 2020 Survey/reported WHO/UNICEF
67 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
2 (1 - 2) 2014 Survey/reported Larney et al, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
1.6 2021 Survey/reported UNAIDS, 2021
HepB birth dose policy
Yes
Year of birth dose introduction
2000
Eligible for HBV generic medicines
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.5 (0.20 - 0.80) 2015 Modelled Blach et al, 2017
1.39 (1.12 - 1.70) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.38 (1.11 - 1.70) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.37 (1.10 - 1.69) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.38 (1.12 - 1.71) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.39 (1.13 - 1.71) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.35 (1.09 - 1.65) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (1.01 - 1.53) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.14 (0.92 - 1.39) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.84 - 1.27) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.79 - 1.22) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.79 - 1.22) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.80 - 1.23) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.81 - 1.25) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.82 - 1.26) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.82 - 1.27) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.82 - 1.26) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.82 - 1.26) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.81 - 1.25) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.81 - 1.25) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.81 - 1.24) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.86 - 1.32) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.22 (0.98 - 1.49) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.39 (1.13 - 1.71) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.54 (1.25 - 1.89) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.30 - 1.99) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.62 (1.31 - 2.01) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.31 - 2.01) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.30 - 2.02) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.29 - 2.02) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.62 (1.28 - 2.01) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.07 - 1.63) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.46 (0.16 - 0.72) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.8 (0.40 - 2) 2014 Survey/reported Gower et al, 2014
0.8 2019 Modelled Jin et al. 2017
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
30.8 (9.10 - 61.40) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
89.2 (85.30 - 92.30) 2015 Survey/reported PKNI, 2014
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
28 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
1,289,000 (443,000 - 2,046,000) 2015 Modelled Blach et al, 2017
2,940,510 (2,332,900 - 3,644,430) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2,997,380 (2,381,230 - 3,712,340) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3,044,680 (2,431,600 - 3,768,190) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3,083,000 (2,468,780 - 3,809,640) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3,112,840 (2,502,460 - 3,839,230) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3,134,740 (2,527,980 - 3,860,320) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3,038,390 (2,454,030 - 3,729,630) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,778,240 (2,244,660 - 3,405,970) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,457,710 (1,979,450 - 3,015,440) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,187,080 (1,753,120 - 2,689,300) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,083,530 (1,667,860 - 2,563,180) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,108,290 (1,686,030 - 2,599,640) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2,139,150 (1,715,900 - 2,643,420) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2,173,230 (1,745,020 - 2,687,630) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2,206,570 (1,772,930 - 2,727,180) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2,236,590 (1,798,590 - 2,762,450) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2,251,570 (1,807,910 - 2,785,630) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2,249,480 (1,802,910 - 2,785,160) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2,244,590 (1,794,910 - 2,779,230) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2,252,000 (1,803,890 - 2,785,160) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2,287,820 (1,834,860 - 2,820,750) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2,427,030 (1,956,130 - 2,982,970) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2,684,310 (2,172,500 - 3,293,530) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2,982,990 (2,419,740 - 3,654,860) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3,242,230 (2,626,460 - 3,971,530) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3,377,220 (2,732,310 - 4,141,370) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3,388,380 (2,738,300 - 4,170,680) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3,393,500 (2,725,100 - 4,182,180) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3,426,150 (2,759,540 - 4,210,150) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3,444,760 (2,786,340 - 4,236,890) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3,463,750 (2,803,600 - 4,256,520) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
326,000 (112,000 - 518,000) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
12.7 (10.30 - 15.10) 2019 Modelled IHME, GBD 2019 (accessed 2020)
11.12 (9.39 - 12.81) 1990 Modelled IHME, GBD 2019 (accessed 2022)
11.17 (9.41 - 12.93) 1991 Modelled IHME, GBD 2019 (accessed 2022)
11.24 (9.54 - 13.01) 1992 Modelled IHME, GBD 2019 (accessed 2022)
11.36 (9.61 - 13.04) 1994 Modelled IHME, GBD 2019 (accessed 2022)
11.31 (9.61 - 13.33) 1993 Modelled IHME, GBD 2019 (accessed 2022)
11.42 (9.62 - 13.11) 1995 Modelled IHME, GBD 2019 (accessed 2022)
11.48 (9.85 - 13.26) 1996 Modelled IHME, GBD 2019 (accessed 2022)
11.52 (9.88 - 13.28) 1997 Modelled IHME, GBD 2019 (accessed 2022)
11.66 (10.04 - 13.35) 1999 Modelled IHME, GBD 2019 (accessed 2022)
11.58 (10.02 - 13.26) 1998 Modelled IHME, GBD 2019 (accessed 2022)
11.72 (10.07 - 13.52) 2000 Modelled IHME, GBD 2019 (accessed 2022)
11.72 (10.03 - 13.45) 2001 Modelled IHME, GBD 2019 (accessed 2022)
11.7 (10.15 - 13.29) 2002 Modelled IHME, GBD 2019 (accessed 2022)
11.69 (10.14 - 13.32) 2003 Modelled IHME, GBD 2019 (accessed 2022)
11.73 (10.18 - 13.46) 2004 Modelled IHME, GBD 2019 (accessed 2022)
11.81 (10.16 - 13.52) 2005 Modelled IHME, GBD 2019 (accessed 2022)
11.96 (10.25 - 13.76) 2006 Modelled IHME, GBD 2019 (accessed 2022)
12.15 (10.52 - 13.92) 2007 Modelled IHME, GBD 2019 (accessed 2022)
12.39 (10.76 - 14.24) 2008 Modelled IHME, GBD 2019 (accessed 2022)
12.61 (10.92 - 14.40) 2009 Modelled IHME, GBD 2019 (accessed 2022)
12.7 (10.98 - 14.66) 2010 Modelled IHME, GBD 2019 (accessed 2022)
12.78 (11.04 - 14.77) 2011 Modelled IHME, GBD 2019 (accessed 2022)
12.66 (10.90 - 14.72) 2012 Modelled IHME, GBD 2019 (accessed 2022)
12.59 (10.69 - 14.62) 2013 Modelled IHME, GBD 2019 (accessed 2022)
12.27 (10.26 - 14.35) 2015 Modelled IHME, GBD 2019 (accessed 2022)
12.51 (10.53 - 14.43) 2014 Modelled IHME, GBD 2019 (accessed 2022)
12.36 (10.26 - 14.44) 2016 Modelled IHME, GBD 2019 (accessed 2022)
12.52 (10.20 - 14.97) 2017 Modelled IHME, GBD 2019 (accessed 2022)
12.6 (10.31 - 14.93) 2018 Modelled IHME, GBD 2019 (accessed 2022)
12.67 (10.35 - 15.08) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
15,435 2016 Modelled WHO
32,869 (26,846 - 39,132) 2019 Modelled IHME, GBD 2019 (accessed 2022)
32,869 (26,846 - 39,132) 2019 Modelled IHME, GBD 2019 (accessed 2020)
32,468 (26,567 - 38,478) 2018 Modelled IHME, GBD 2019 (accessed 2022)
32,050 (26,119 - 38,315) 2017 Modelled IHME, GBD 2019 (accessed 2022)
31,410 (26,074 - 36,699) 2016 Modelled IHME, GBD 2019 (accessed 2022)
30,924 (25,862 - 36,191) 2015 Modelled IHME, GBD 2019 (accessed 2022)
31,276 (26,333 - 36,088) 2014 Modelled IHME, GBD 2019 (accessed 2022)
31,208 (26,500 - 36,243) 2013 Modelled IHME, GBD 2019 (accessed 2022)
31,088 (26,761 - 36,147) 2012 Modelled IHME, GBD 2019 (accessed 2022)
31,068 (26,839 - 35,910) 2011 Modelled IHME, GBD 2019 (accessed 2022)
30,563 (26,438 - 35,287) 2010 Modelled IHME, GBD 2019 (accessed 2022)
30,035 (26,017 - 34,298) 2009 Modelled IHME, GBD 2019 (accessed 2022)
29,183 (25,338 - 33,542) 2008 Modelled IHME, GBD 2019 (accessed 2022)
28,297 (24,498 - 32,425) 2007 Modelled IHME, GBD 2019 (accessed 2022)
27,530 (23,602 - 31,671) 2006 Modelled IHME, GBD 2019 (accessed 2022)
26,860 (23,111 - 30,739) 2005 Modelled IHME, GBD 2019 (accessed 2022)
26,350 (22,885 - 30,257) 2004 Modelled IHME, GBD 2019 (accessed 2022)
25,962 (22,521 - 29,578) 2003 Modelled IHME, GBD 2019 (accessed 2022)
25,659 (22,246 - 29,131) 2002 Modelled IHME, GBD 2019 (accessed 2022)
25,356 (21,702 - 29,115) 2001 Modelled IHME, GBD 2019 (accessed 2022)
25,040 (21,511 - 28,889) 2000 Modelled IHME, GBD 2019 (accessed 2022)
24,574 (21,173 - 28,143) 1999 Modelled IHME, GBD 2019 (accessed 2022)
24,101 (20,846 - 27,590) 1998 Modelled IHME, GBD 2019 (accessed 2022)
23,641 (20,273 - 27,260) 1997 Modelled IHME, GBD 2019 (accessed 2022)
23,233 (19,943 - 26,851) 1996 Modelled IHME, GBD 2019 (accessed 2022)
22,799 (19,202 - 26,178) 1995 Modelled IHME, GBD 2019 (accessed 2022)
22,366 (18,912 - 25,676) 1994 Modelled IHME, GBD 2019 (accessed 2022)
21,943 (18,651 - 25,859) 1993 Modelled IHME, GBD 2019 (accessed 2022)
21,490 (18,230 - 24,879) 1992 Modelled IHME, GBD 2019 (accessed 2022)
21,031 (17,709 - 24,343) 1991 Modelled IHME, GBD 2019 (accessed 2022)
20,620 (17,414 - 23,748) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
8 (7 - 9) 1990 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 10) 1991 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 10) 1992 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 11) 1995 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 1994 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 10) 1993 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 11) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 11) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2002 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 11) 2004 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 12) 2003 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 12) 2006 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 13) 2007 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 12) 2008 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 12) 2009 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 12) 2010 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 12) 2011 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 13) 2013 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 13) 2012 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 13) 2014 Modelled IHME, GBD 2019 (accessed 2022)
12 (11 - 13) 2015 Modelled IHME, GBD 2019 (accessed 2022)
12 (11 - 13) 2016 Modelled IHME, GBD 2019 (accessed 2022)
12 (11 - 14) 2017 Modelled IHME, GBD 2019 (accessed 2022)
12 (11 - 14) 2018 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 14) 2019 Modelled IHME, GBD 2019 (accessed 2022)
46 (41 - 50) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
400 2016 Survey/reported WHO, 2018
400 2016 Survey/reported WHO, 2018
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
2 (1 - 2) 2014 Survey/reported Larney et al, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
1.6 2021 Survey/reported UNAIDS, 2021
HepB birth dose policy
Yes
Year of birth dose introduction
2000
Eligible for HBV generic medicines
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
22,614
2019
(18,419 - 27,519)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
32,869
2019
(26,846 - 39,132)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
70 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
2
2014
(1 - 2)
Larney et al, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources

Partners